Potential target for reversing drug resistance in ovarian cancer identified

For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.

Leave A Comment

Your email address will not be published. Required fields are marked *